News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,736 Results
Type
Article (41441)
Company Profile (263)
Press Release (691019)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (204878)
Career Advice (2034)
Deals (35602)
Drug Delivery (132)
Drug Development (81562)
Employer Resources (173)
FDA (16524)
Job Trends (14991)
News (346919)
Policy (32751)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2603)
Accelerated approval (53)
Adcomms (27)
Allergies (177)
Alliances (49581)
ALS (218)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (490)
Approvals (16945)
Artificial intelligence (692)
Autoimmune disease (318)
Automation (58)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (783)
Cancer (6099)
Cardiovascular disease (487)
Career advice (1729)
Career pathing (44)
CAR-T (346)
CDC (57)
Celiac Disease (3)
Cell therapy (933)
Cervical cancer (51)
Clinical research (71200)
Collaboration (2121)
Company closure (5)
Compensation (1453)
Complete response letters (82)
COVID-19 (2749)
CRISPR (111)
C-suite (1170)
Cystic fibrosis (155)
Data (8353)
Decentralized trials (3)
Denatured (28)
Depression (165)
Dermatology (93)
Diabetes (637)
Diagnostics (6988)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92173)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120208)
Executive appointments (1098)
FDA (20371)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1771)
Gene editing (238)
Generative AI (59)
Gene therapy (732)
GLP-1 (1077)
Government (4740)
Grass and pollen (6)
Guidances (414)
Healthcare (19124)
HIV (82)
Huntington's disease (58)
IgA nephropathy (109)
Immunology and inflammation (291)
Immuno-oncology (99)
Indications (201)
Infectious disease (3103)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (302)
Interviews (320)
IPO (16670)
IRA (50)
Job creations (3649)
Job search strategy (1431)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (567)
Leadership (41)
Legal (7953)
Liver cancer (102)
Longevity (33)
Lung cancer (815)
Lymphoma (449)
Machine learning (61)
Management (59)
Manufacturing (1090)
MASH (202)
Medical device (13959)
Medtech (14102)
Mergers & acquisitions (20202)
Metabolic disorders (1589)
mRNA (217)
Multiple sclerosis (194)
NASH (17)
Neurodegenerative disease (436)
Neuropsychiatric disorders (106)
Neuroscience (3382)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4534)
Now hiring (79)
Obesity (734)
Opinion (291)
Ovarian cancer (233)
Pain (259)
Pancreatic cancer (327)
Parkinson's disease (378)
Partnered (33)
Patents (611)
Patient recruitment (700)
Peanut (65)
People (59718)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22200)
Phase 2 (31368)
Phase 3 (23339)
Pipeline (9321)
Policy (323)
Postmarket research (2569)
Preclinical (9445)
Press Release (64)
Prostate cancer (323)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1110)
Real estate (5973)
Recruiting (70)
Regulatory (25581)
Reports (56)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (180)
Series A (297)
Series B (217)
Service/supplier (11)
Sickle cell disease (117)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3644)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (87)
The Weekly (64)
Vaccines (1120)
Venture capital (114)
Weight loss (468)
Women's health (131)
Worklife (20)
Date
Today (94)
Last 7 days (729)
Last 30 days (2952)
Last 365 days (30283)
2026 (14499)
2025 (30167)
2024 (35208)
2023 (40072)
2022 (51173)
2021 (55706)
2020 (54080)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (14)
Asia (39813)
Australia (6527)
California (13685)
Canada (3860)
China (1425)
Colorado (582)
Connecticut (599)
Delaware (422)
Europe (86158)
Florida (2045)
Georgia (438)
Hawaii (3)
Idaho (63)
Illinois (1105)
India (93)
Indiana (619)
Iowa (23)
Japan (563)
Kansas (132)
Kentucky (50)
Louisiana (55)
Maine (76)
Maryland (1634)
Massachusetts (9771)
Michigan (370)
Minnesota (738)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3585)
New Mexico (30)
New York (3580)
North Carolina (1727)
North Dakota (9)
Northern California (6892)
Ohio (409)
Oklahoma (23)
Oregon (41)
Pennsylvania (2736)
Puerto Rico (29)
Rhode Island (51)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5415)
Tennessee (217)
Texas (2182)
United States (48217)
Utah (405)
Vermont (1)
Virginia (330)
Washington D.C. (81)
Washington State (1094)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,736 Results for "microvention inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
MicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United States
MicroVention, Inc. announced that the LVIS™ EVO™ Intraluminal Support Device is now commercially available in the United States for the treatment of wide neck intracranial aneurysms.
June 26, 2024
·
4 min read
Biotech Beach
MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the company’s FRED™ X Flow Diverter.
July 31, 2023
·
4 min read
BioMidwest
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
MicroVention, Inc. is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters, with more than half a million worldwide procedures performed across 170 countries, and 30+ articles published globally since it was first introduced ten years ago.
November 16, 2023
·
5 min read
Biotech Beach
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access.
September 21, 2023
·
3 min read
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Biotech Beach
MicroVention Reshapes Stroke Therapy with the Introduction of the ERIC™ Retrieval Device; ERIC Delivers Thrombus Control, Procedure Efficiency and Versatility When Every Second Counts
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced that the ERIC Retrieval Device is now commercially available in the United States for ischemic stroke treatment.
June 27, 2023
·
5 min read
Biotech Beach
MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year follow-up data and the addition of two sizes to its WEB Aneurysm Embolization System.
July 31, 2023
·
6 min read
Biotech Beach
MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives
MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022.
September 29, 2022
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
1 of 73,274
Next
